Prevalence of hepatitis B and C infection in hemodialysis patients of Rasht (Center of Guilan Province, Northern part of Iran)

Hepatitis Monthly

Volumn 9, Issue 1, 2009, Pages 45-49

  Mansour Ghanael, Fariborz ^a   Sadeghi, Ahmad ^a   Mashhour, Mahmoud Yousefi ^a   Joukar, Farahnaz ^a   Besharati, Sepiedeh ^a   Roshan, Zahra Atrkar ^a   Khosh Sorur, Mahmoud ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hemodialysis; Hepatitis B; Hepatitis C

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD ANALYSIS; CROSS-SECTIONAL STUDY; DATA COLLECTION METHOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS C; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TREATMENT DURATION;

EID: 67649380555     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002;36(1):3-10.
2. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: Changing the epidemiology. Hemodial Int. 2008;12(3):378-82.
3. Garibaldi RA, Forrest JN, Bryan JA, Hanson BF, Dismukes WE. Hemodialysis-associated hepatitis. JAMA. 1973;225(4):384-9.
4. Goffin E, Pirson Y, van Ypersele de Strihou C. Implications of chronic hepatitis B or hepatitis C infection for renal transplant candidates. Nephrol Dial Transplant. 1995;10 Suppl 6:88-92.
5. Carrilho F, Correa, MCJM. Magnitude of hepatitis B and C in Latin America. In: Schinazi RF S, JP,Thomas HC, editor. Therapy for Viral Hepatitis. London: Int Med Press; 1998. p. 25-34.
6. Carrilho FJ, Moraes CR, Pinho JR, et al. Hepatitis B virus infection in Hemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology. BMC Public Health. 2004;4:13.
7. Botte C, Janot C. Epidemiology of HCV infection in the general population and in blood transfusion. Nephrol Dial Transplant. 1996;11 Suppl 4:19-21.
8. Degos F. Natural history of hepatitis C virus infection. Nephrol Dial Transplant. 1996;11 Suppl 4:16-8.
9. Fornasieri A, D'Amico G. Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritis. Nephrol Dial Transplant. 1996;11 Suppl 4:25-30.
10. Henderson DK. Managing occupational risks for hepatitis C transmission in the health care setting. Clin Microbiol Rev. 2003; 16(3):546-68.
11. Sulowicz W, Radziszewski A, Chowaniec E. Hepatitis C virus infection in dialysis patients. Hemodial Int. 2007;11(3):286-95.
12. Chlabicz S, Flisiak R, Grzeszczuk A, Kovalchuk O, Prokopowicz D, Chyczewski L. Known and probable risk factors for hepatitis C infection: a case series in northeastern Poland. World J Gastroenterol. 2006;12(1):141-5.
13. Barril G, Traver JA. Decrease in the hepatitis C virus (HCV) prevalence in hemodialysis patients in Spain: effect of time, initiating HCV prevalence studies and adoption of isolation measures. Antiviral Res. 2003;60(2):129-34.
14. Garcia-Valdecasas J, Bernal C, Garcia F, Leyva A, Cerezo S. Epidemiological factors involved in hepatitis C virus infection in patients with renal disease. Nephrol Dial Transplant. 1995; 10 Suppl 6:81-2.
15. Olmer M, Bouchouareb D, Zandotti C, de Micco P, de Lamballerie X. Transmission of the hepatitis C virus in an hemodialysis unit: evidence for nosocomial infection. Clin Nephrol. 1997;47(4):263-70.
16. Fabrizi F, Martin P, Dixit V, et al. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis. 2000;35(1):122-9.
17. Saab S, Martin P, Brezina M, Gitnick G, Yee HF, Jr. Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis. Am J Kidney Dis. 2001;37(2): 308-15.
18. Seme K, Poljak M, Zuzec-Resek S, Debeljak M, Dovc P, Koren S. Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit. Nephron. 1997; 77(3):273-8.
19. Sampietro M, Badalamenti S, Graziani G. Nosocomial hepatitis C in dialysis units. Nephron. 1996;74(2):251-60.
20. Taskapan H, Oymak O, Dogukan A, Utas C. Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin Nephrol. 2001; 55(6):477-81.
21. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis. 2003; 42(4):631-57.
22. Fabrizi F, de Vecchi AF, Como G, Lunghi G, Martin P. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Aliment Pharmacol Ther. 2005; 21(7):861-9.
23. Antonova TV, Kostereva EV, Kunznecova MY, Kubar OI. Viral hepatitis C in hemodialysis. Epi North. 2001;2(b3):42-4.
24. Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N. [Prevalence of hepatitis C, hepatitis B and HIV infection among hemodialysis patients in Ibn-Rochd university hospital, Casablanca]. Nephrol Ther. 2005;1(5): 274-84.
25. Yakaryilmaz F, Gurbuz OA, Guliter S, et al. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail. 2006;28(8):729-35.
26. Otedo AE, Mc'Ligeyo SO, Okoth FA, Kayima JK. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J. 2003;93(5):380-4.
27. Thanachartwet V, Phumratanaprapin W, Desakorn V, et al. Viral hepatitis infections among dialysis patients: Thailand registry report. Nephrology (Carlton). 2007;12(4): 399-405.
28. Ishida T, Takao S, Settheetham-Ishida W, Tiwawech D. Prevalence of hepatitis B and C virus infection in rural ethnic populations of Northern Thailand. J Clin Virol. 2002;24(1-2):31-5.
29. Teles SA, Martins RM, Silva SA, et al. Hepatitis B virus infection profile in central Brazilian hemodialysis population. Rev Inst Med Trop Sao Paulo. 1998;40(5):281-6.
30. Reddy GA, Dakshinamurthy KV, Neelaprasad P, Gangadhar T, Lakshmi V. Prevalence of HBV and HCV dual infection in patients on hemodialysis. Indian J Med Microbiol. 2005;23(1):41-3.
31. Kheradpezhouh M, Taremi M, Gachkar L, Aghabozorgi S, Khoshbaten M. Presence and significance of transfusion-transmitted virus infection in Iranian patients on maintenance hemodialysis. Journal of Microbiology Immunology and Infection. 2007;40(2):106.
32. Vladutiu DS, Cosa A, Neamtu A, et al. Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map? J Viral Hepat. 2000;7(4):313-9.
33. Alavian SM, Hosseini-Moghaddam SM, Rahnavardi M. Hepatitis C among Hemodialysis Patients: A Review on Epidemiologic, Diagnostic, and Therapeutic Features. Hep Mon. 2007;7:153-62.
34. Bocsan IS, Neamtu A, Radulescu A, et al. [The markers of hepatitis B, C and D viral infection in multiply transfused patients]. Bacteriol Virusol Parazitol Epidemiol. 1995;40(2):109-13.
35. Harmankaya O, Cetin B, Obek A, Seber E. Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation? Ren Fail. 2002;24(5):639-44.
36. Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian hemodialysis patients. Nephrology (Carlton). 2003; 8(5): 256-60.
37. Cooreman MP, Schoondermark-Van de Ven EM. Hepatitis C virus: biological and clinical consequences of genetic heterogeneity. Scand J Gastroenterol Suppl. 1996;218:106-15.
38. Lombardi M, Dattolo P, Ferro G, Michelassi S. [Prevention of HCV infection in the hemodialysis setting.]. G Ital Nefrol. 2007; 24(3):202-11.
39. Carneiro MA, Martins RM, Teles SA, et al. Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods. Mem Inst Oswaldo Cruz. 2001;96(6): 765-9.
40. Elisaf M, Tsianos E, Mavridis A, Dardamanis M, Pappas M, Siamopoulos KC. Antibodies against hepatitis C virus (anti-HCV) in hemodialysis patients: association with hepatitis B serological markers. Nephrol Dial Transplant. 1991;6(7):476-9.